Open AccessAngiotensin II Type 1 Receptor Blockade Prevents Alcoholic Cardiomyopathy
Author(s) -
ChePing Cheng,
Heng-Jie Cheng,
Carol Cunningham,
Zakariya K. Shihabi,
David C. Sane,
Thomas Wannenburg,
William C. Little
Publication year - 2006
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.105.596494
Subject(s) - alcoholic cardiomyopathy , medicine , irbesartan , endocrinology , angiotensin ii , angiotensin ii receptor type 1 , cardiomyopathy , renin–angiotensin system , contractility , heart failure , receptor , blood pressure
Activation of the renin-angiotensin system (RAS) may contribute to the development of alcoholic cardiomyopathy. We evaluated the effect of angiotensin II (Ang II) type 1 receptor (AT1) blockade on the development of alcoholic cardiomyopathy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom